Moreover, expression of both Gas6 and Axl is increased in ovarian, endometrial and prostate carcinomas (Sun et al, 2003, 2004; Sainaghi et al, 2005), confirming expression of these potential targets in hormone-responsive tumours. Here, AXL is linked to prostate carcinoma.